Related Experiment Video

Updated: Sep 28, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Probiotics--role in inflammatory bowel disease

P Gionchetti1, C Amadini, F Rizzello

  • 1IBD Unit, Department of Internal Medicine and Gastroenterology, University of Bologna, Italy. paolo@med.unibo.it

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|November 1, 2002
PubMed

Insights

Probiotic therapy shows promise for inflammatory bowel disease (IBD) management, particularly in preventing pouchitis. Further large-scale trials are needed to confirm efficacy in ulcerative colitis and Crohn

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The exact cause of inflammatory bowel disease (IBD) remains unknown.
  • Intestinal bacteria are implicated in IBD pathogenesis, supporting the rationale for probiotic therapy.
  • Animal models of colitis show positive responses to probiotics.

Purpose of the Study:

  • To evaluate the potential of probiotic therapy in managing inflammatory bowel disease.
  • To assess the efficacy of concentrated probiotic preparations in preventing pouchitis.
  • To explore the role of probiotics in ulcerative colitis and Crohn's disease.

Main Methods:

  • Review of evidence supporting probiotic use in IBD.
  • Analysis of results from animal models of experimental colitis.
  • Assessment of probiotic preparations for pouchitis prevention and relapse management.

Main Results:

  • Probiotic therapy has demonstrated encouraging outcomes in animal models.
  • Highly concentrated probiotic preparations appear effective in preventing pouchitis onset and relapses.
  • Preliminary results in ulcerative colitis and Crohn's disease are promising.

Conclusions:

  • Probiotic therapy is a potential therapeutic strategy for inflammatory bowel disease.
  • Concentrated probiotics offer a valid approach for pouchitis management.
  • Larger double-blind trials are necessary to validate these findings for ulcerative colitis and Crohn's disease.

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...